Oral GLP-1 drug promotes substantial weight loss in trial
September 23, 2025
September 23, 2025
ITHACA, New York, Sept. 23 -- Cornell University posted the following news:
* * *
Oral GLP-1 drug promotes substantial weight loss in trial
*
Patients taking an experimental oral GLP-1 drug lost significant weight and improved heart and metabolic risk factors in a large, international phase III clinical trial led by investigators at Weill Cornell Medicine, McMaster University, York University and other institutions.
The results fr . . .
* * *
Oral GLP-1 drug promotes substantial weight loss in trial
*
Patients taking an experimental oral GLP-1 drug lost significant weight and improved heart and metabolic risk factors in a large, international phase III clinical trial led by investigators at Weill Cornell Medicine, McMaster University, York University and other institutions.
The results fr . . .